ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹179 Cr | ₹153 Cr | ₹161 Cr | ₹131 Cr | ₹139 Cr |
What is the latest Total Current Liabilities ratio of ANUH PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹179 Cr |
| Mar2024 | ₹153 Cr |
| Mar2023 | ₹161 Cr |
| Mar2022 | ₹131 Cr |
| Mar2021 | ₹139 Cr |
How is Total Current Liabilities of ANUH PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹179 Cr | 16.91 | |
| Mar2024 | ₹153 Cr | -5.36 | |
| Mar2023 | ₹161 Cr | 23.24 | |
| Mar2022 | ₹131 Cr | -6.14 | |
| Mar2021 | ₹139 Cr | - | |
Compare Total Current Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹827.2 Cr | 1.6% | 15.4% | -3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 1.6% |
15.4% |
-3.4% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses